Sort
21,453 grants matching “tuberculosis”
Understanding and Improving the Effectiveness of Public Health Laboratory Networks for Infectious Diseases in Ghana
$677,548Lee Frederick Schroeder · University Of Michigan At Ann Arbor · R01 · FY2021 · AI
Clinical Core
$677,331Richard Douglas Moore · Johns Hopkins University · P30 · FY2017 · AI
Quit4Life+: Adapting and Evaluating a Phone-Based Tobacco Use Cessation Program for People Living with HIV in Uganda and Zambia
$677,035Heather L Wipfli · University Of Southern California · U01 · FY2022 · CA
Lung immune function in human TB infection and its perturbation by HIV-1.
$676,988David G Russell · Cornell University · R01 · FY2020 · AI
TUBERCULOSIS ELIMINATION AND LABORATORY COOPERATIVE AGREEMENT
$676,964Greduvel Duran-Guzman · Puerto Rico Department Of Health · U52 · FY2014 · PS
Modulation of epigenetic programming of tissue resident macrophage lineages to impact HIV-1 infection, maintenance, and persistence.
$676,923David G Russell · Cornell University · R01 · FY2024 · AI
A longitudinal cohort study to evaluate cardiovascular risk factors and disease in Haiti
$676,813Margaret Leighton McNairy · Weill Medical Coll Of Cornell Univ · R01 · FY2018 · HL
Innovating anti-tuberculosis drug susceptibility testing with a novel and rapid non-culture based phenotypic test using MPT64 biomarker
$676,791Midori Kato-Maeda · University Of California, San Francisco · R01 · FY2023 · AI
New radiotracer development to study immune cell mobilization of granzyme proteolytic activity
$676,766Michael John Evans · University Of California, San Francisco · R01 · FY2021 · AI
HIV-TB Co-infection: Tracking TB emergence after asymptomatic (latent) infection
$676,755Philana Ling Lin · University Of Pittsburgh At Pittsburgh · R01 · FY2017 · AI
Assembly and export of mycobacterial lipoglycans
$676,504Mary Jackson · Colorado State University · R01 · FY2021 · AI
Immunology and Outcomes after HAART in HIV/TB Coinfection
$676,454Gregory P. Bisson · University Of Pennsylvania · R01 · FY2010 · AI
Eliciting lung-localized CD4 T cell responses against Mycobacterium tuberculosis in preventive and post-exposure settings
$676,352Kevin B Urdahl · Seattle Children'S Hospital · R01 · FY2020 · AI
Task 4: The Interventional Agent Development Services program
$676,000Jon Carl Mirsalis · Sri International · N01 · FY2016 · AI
Targeting trans-translation to kill M. tuberculosis non-replicating persister cells
$675,928Kenneth C Keiler · University Of Texas At Austin · R01 · FY2025 · AI
Clinical Trial of Short Course vs. INH for LTBI in Jail
$675,773Mary Castle White · University Of California, San Francisco · U01 · FY2006 · AI
Toll-like receptor control of endocytic antigen cross-presentation
$675,627Julie Magarian Blander · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · AI
Toll-like receptor control of endocytic antigen cross-presentation
$675,627Julie Magarian Blander · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · AI
Toll-like receptor control of endocytic antigen cross-presentation
$675,627Julie Magarian Blander · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · AI
Socio-spatial Networks and Tuberculosis Infection in Youth in Rural Uganda
$675,619Carina Marquez · University Of California, San Francisco · R01 · FY2023 · AI
Multivalent DNA vaccine-mediated protection against Tuberculosis
$675,566David B. Weiner · Wistar Institute · R01 · FY2018 · AI
Clinical
$675,535Rajesh T Gandhi · Harvard University · P30 · FY2010 · AI
Sepsis Characterization in Kilimanjaro
$675,496Matthew P Rubach · Duke University · R01 · FY2024 · AI
Socio-spatial Networks and Tuberculosis Infection in Youth in Rural Uganda
$675,457Carina Marquez · University Of California, San Francisco · R01 · FY2024 · AI
Mycobacterial Lung Diseases in Virginia: sequencing and clinical determinants of relapse and outcome
$675,436Eric R Houpt · University Of Virginia · R01 · FY2022 · HL